FDA 483 - Vericel Corporation - July 21, 2023

Vericel Corporation in Cambridge, MA, a manufacturer of cell therapy and medical devices, was inspected by the FDA from July 13-21, 2023. The inspection revealed significant deficiencies in aseptic processing, environmental monitoring, quality control, and design verification for their MACI product. These issues indicate potential risks to product sterility and quality assurance.